Analysis of C=C Positions of Lipids in Mouse Brain Sections Using MALDI-OAD-MS/MS

Analysis of C=C Positions of Lipids in Mouse Brain Sections Using MALDI-OAD-MS/MS

Significance of the topic

Lipids play central roles in cell structure, signaling and metabolism; the position of carbon–carbon double bonds (C=C) within fatty acyl chains crucially influences lipid biophysical properties and biological function. Accurate, spatially resolved determination of double-bond positions in tissue sections advances neurochemical mapping, biomarker discovery and mechanistic studies of lipid metabolism in health and disease. A method that identifies C=C positions directly on sections without extraction streamlines workflows for imaging mass spectrometry and preserves spatial context.

Objectives and overview of the study

The study demonstrates the application of oxygen attachment dissociation tandem mass spectrometry (OAD‑MS/MS) combined with MALDI imaging to localize C=C positions of lipids in mouse cerebellum sections. The goals were to (1) show that OAD‑MS/MS identifies C=C positional isomers directly from tissue, (2) verify applicability to both proton and alkali metal adducts and to positive and negative ion polarities, and (3) integrate OAD‑TOF MS/MS with an imaging mass microscope (iMScope QT) for spatially resolved lipid isomer analysis.

Methodology and sample preparation

• Tissue preparation: Frozen mouse brain; cryosections 10 µm thick mounted on ITO-coated slides.
• Salt removal: Sections washed three times with 50 mM ammonium formate at 4 °C to reduce metal adducts and improve protonated species detection.
• Matrix deposition: 2,5-dihydroxybenzoic acid (DHB) applied via an automated iMLayer deposition system to an approximate coating thickness of 1.2 µm.
• Imaging acquisition: MALDI imaging with OAD‑MS/MS performed across the cerebellar region in both positive and negative ion modes to probe different lipid classes.
• Data processing: Spectral imaging and MS/MS data analyzed using IMAGEREVEAL MS to identify OAD fragment neutral losses and assign C=C positions.

Used instrumentation

• Imaging platform: iMScope QT imaging mass microscope for MALDI imaging and spatial acquisition.
• Mass spectrometer and OAD source: LCMS‑9050 equipped with the OAD RADICAL SOURCE I (OAD‑TOF system). The OAD source generates atomic oxygen and hydroxyl radicals (O/OH•) from a water vapor/hydrogen gas mixture using a microwave-driven radical source; radicals are introduced into the Q2 cell for radical-driven fragmentation.
• Matrix deposition system: iMLayer automated sprayer for reproducible DHB coatings.
• Representative acquisition parameters (summarized): MS/MS m/z range 500–920; spatial pitch 50 µm; laser repetition frequency 100 Hz; Q1 isolation resolution ~5 Da; collision energy ~10 V. Desolvation/heat block temperatures and laser settings were optimized for MALDI‑OAD imaging (reported DL ~290 °C, heat block ~400 °C in the original method).

Main results and discussion

• Positive ion mode — phosphatidylcholine (PC) 16:0_18:1: Using DHB, PC 16:0_18:1 was detected both as alkali adducts and as protonated species after washing. The [M+K]+ ion (m/z 798.543, unwashed) and [M+H]+ (m/z 760.584, washed) served as precursors for MALDI‑OAD‑MS/MS. Radical-driven OAD fragmentation produced diagnostic product ions that unambiguously report C=C locations consistent with n‑7 and n‑9 isomers. Imaging showed PC 16:0_18:1(n‑9) to be substantially more abundant in the cerebellar region than the n‑7 isomer.
• Negative ion mode — sulfatide (SHexCer) d18:1/24:1: The deprotonated precursor [M−H]− at m/z 888.623 yielded OAD fragments indicating two distinct double-bond loci, interpreted as Δ4 in the sphingoid base and n‑9 in the 24:1 acyl chain. This confirms applicability to sphingolipids and to negative polarity analyses.
• Mechanistic advantage: OAD employs neutral oxygen/hydroxyl radicals to selectively cleave C=C bonds via radical attack, producing diagnostic neutral losses and fragments that localize double bonds. Because radicals are neutral, OAD fragmentation can be applied irrespective of precursor charge (protonated, metal‑adducted or deprotonated), enabling broad compatibility with lipid ion forms observed in MALDI imaging.
• Spatially resolved structural lipidomics: Combining OAD‑MS/MS with imaging enables direct mapping of double‑bond positional isomers across tissue microanatomy without prior lipid extraction, preserving localization information and simplifying sample handling.

Benefits and practical applications

• Direct on‑tissue C=C localization: Eliminates lipid extraction and derivatization steps, reducing sample processing time and potential artifacts.
• Broad ion compatibility: Effective for protonated, alkali‑adducted and deprotonated precursors and for both positive and negative ion modes.
• Imaging capability: Enables spatial mapping of isomer distributions, useful for neuroscience studies, biomarker discovery, pathology, and pharmacology where localization matters.
• Complementary to CID: OAD provides double‑bond‑specific information that complements collision‑induced dissociation approaches which preferentially fragment labile sites and can miss C=C diagnostic cleavages.

Limitations and practical considerations

• Instrumentation requirement: Implementation requires an OAD radical source integrated into a suitable MS/MS platform (here an OAD‑TOF/Q‑TOF configuration) and coupling to a MALDI imaging system.
• Sensitivity and abundance: Low‑abundance isomers may be challenging to detect; matrix application and washing steps must be optimized to enhance specific ion forms.
• Spatial resolution: Demonstrated spatial pitch was ~50 µm; higher‑resolution imaging would require further optimization of sample preparation, laser focus, and sensitivity.
• Data interpretation: Assignment of C=C positions depends on observing specific neutral losses and fragments; complex mixtures and overlapping peaks may demand careful spectral deconvolution and software support.

Future trends and possibilities for use

• Higher spatial resolution OAD imaging: Pushing toward cellular or subcellular resolution by optimizing laser optics, matrix deposition and instrument sensitivity.
• Integration with quantitative lipidomics: Combining on‑tissue OAD imaging with LC‑MS/MS workflows or internal standards to obtain quantitative maps of positional isomers.
• Automated annotation and databases: Development of software tools and spectral libraries for automated identification of OAD diagnostic fragments will streamline interpretation and broaden adoption.
• Broader lipid class coverage: Extending OAD imaging to glycerophospholipids, sphingolipids, neutral lipids and oxidized species to build comprehensive spatial lipidomics atlases.
• Clinical and translational applications: Use in disease tissue phenotyping, biomarker localization, and assessment of lipid‑modulating therapies where isomer distributions are functionally relevant.

Conclusion

MALDI‑OAD‑MS/MS implemented on an imaging mass microscope coupled with an OAD‑TOF system provides a practical approach to localize C=C positions of lipids directly in tissue sections. The neutral radical fragmentation mechanism enables analysis across ion types and polarities, delivering specific structural information that complements conventional CID. The method simplifies sample preparation, preserves spatial context, and shows promise for advanced spatial lipidomics applications in research and translational settings.

References

1. Takahashi H., et al. Analytical Chemistry, 2018, 90(12), 7230–7238.
2. Takahashi H., et al. Mass Spectrometry, 2019, S0080.
3. Uchino H., et al. Communications Chemistry, 2022, 5, 162.
4. Angel P. M., Peggi M., et al. Analytical Chemistry, 2012, 84(3), 1557–1564.